|
Sep 25
|
A weight loss drug maker is aiming for a big IPO
|
|
Sep 25
|
Why This Stock Could Be the Nvidia of Healthcare
|
|
Sep 25
|
New data show Lilly's EBGLYSS™ (lebrikizumab-lbkz) provided sustained disease control for up to three years in more than 80% of adults and adolescents with moderate-to-severe atopic dermatitis
|
|
Sep 25
|
FDA hits Ozempic and Mounjaro counterfeit compounders with warning letters
|
|
Sep 25
|
MHLW approves Eli Lilly’s Kinsula to treat Alzheimer’s in Japan
|
|
Sep 24
|
Novo Nordisk CEO grilled by Senate committee over GLP-1 prices
|
|
Sep 24
|
Bernie Sanders Tells Ozempic Drug Maker: ‘Stop Ripping Us Off’
|
|
Sep 24
|
Eli Lilly's Early Alzheimer's Treatment Donanemab Scores Japanese Approval, Its Second Largest Market
|
|
Sep 24
|
Eli Lilly's Alzheimer's drug approved in Japan
|
|
Sep 12
|
Eli Lilly doubles down on Irish operations with $1.8 bln Investment
|
|
Sep 12
|
Roche Stock Down on Concerns of Side-Effects From Its Obesity Drug
|
|
Sep 12
|
Dow Jones Futures Rise After 'Incredible' Nvidia Leads Big Upside Market Reversal, 6 Stocks In Buy Areas
|
|
Sep 12
|
Roche Setback Is Big for Eli Lilly, Novo Nordisk Stock as Obesity Drug Battle Ramps Up
|
|
Sep 12
|
Forget Eli Lilly and Novo Nordisk: This Could Be the Best Weight Loss Stock to Buy Right Now
|
|
Sep 12
|
Lilly expands manufacturing footprint in Ireland with $1.8 billion investment
|
|
Sep 12
|
Eli Lilly and Hertz Global have been highlighted as Zacks Bull and Bear of the Day
|
|
Sep 12
|
Bull of the Day: Eli Lilly (LLY)
|
|
Sep 12
|
Roche Shares Drop on Concern About Obesity Pill Side Effects
|
|
Sep 11
|
Novo Nordisk’s new weight-loss pill Amycretin beats Wegovy in early trial
|
|
Sep 11
|
Novo Jumps After Weight-Loss Pill Tops Wegovy; Lilly, Viking Shares Rise
|